Skip to main content

Table 2 Surgical and pathological characteristics a

From: Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy

 

CD0 group (n = 61)

CD1/2 group (n = 44)

CD3/4 group (n = 10)

Total (n = 115)

P Value

Surgical type

    

0.672

     Open

55 (90.2)

42 (95.5)

9 (90.0)

106 (92.2)

 

     MIS

6 (9.8)

2 (4.5)

1 (10.0)

9 (7.8)

 

Gastrectomy

    

0.219

     Subtotal

31 (50.8)

15 (34.1)

5 (50.0)

51 (44.3)

 

     Total

30 (49.2)

29 (65.9)

5 (50.0)

64 (55.7)

 

Surgical radicality

    

0.802

     Radical

37 (60.7)

29 (65.9)

7 (70.0)

73 (63.5)

 

     Palliative

24 (39.3)

15 (34.1)

3 (30.0)

42 (36.5)

 

Lymphadenectomy

    

0.504

     D2

47 (77.0)

31 (70.5)

8 (80.0)

86 (74.8)

 

     D1 plus

13 (21.3)

10 (22.7)

1 (10.0)

24 (20.9)

 

     D1

1 (1.6)

3 (6.8)

1 (10.0)

5 (4.3)

 

Combined resection

    

0.592

     Yes

12 (19.7)

7 (15.9)

3 (30.0)

22 (19.1)

 

     No

49 (80.3)

37 (84.1)

7 (70.0)

93 (80.9)

 

EBLb (mL)

95 (28–300)

126 (30–609)

269 (50–640)

100 (28–640)

0.017

Transfusion

    

<0.001

     Yes

0 (0.0)

17 (38.6)

1 (10.0)

18 (15.7)

 

     No

61 (100.0)

27 (61.4)

9 (90.0)

97 (84.3)

 

Borrmann type

    

0.524

     I

6 (9.8)

2 (4.5)

2 (20.0)

10 (8.7)

 

     II

12 (19.7)

10 (22.7)

1 (10.0)

23 (20.0)

 

     III

32 (52.5)

20 (45.5)

6 (60.0)

58 (50.4)

 

     IV

11 (18.0)

12 (27.3)

1 (10.0)

24 (20.9)

 

Lauren type

    

0.569

     Intestinal

30 (49.2)

23 (52.3)

6 (60.0)

59 (51.3)

 

     Diffuse

26 (42.6)

18 (40.9)

2 (20.0)

46 (40.0)

 

     Mixed

5 (8.2)

3 (6.8)

2 (20.0)

10 (8.7)

 

TNM Stage

    

0.846

     yp 0

4 (6.6)

1 (2.3)

1 (10.0)

6 (5.2)

 

     yp Ia-Ib

14 (23.0)

7 (15.9)

1 (10.0)

22 (19.1)

 

     yp IIa-IIb

6 (9.8)

6 (13.6)

2 (20.0)

14 (12.2)

 

     yp IIIa-IIIc

15 (24.6)

15 (34.1)

3 (30.0)

33 (28.7)

 

     yp IV

22 (36.1)

15 (34.1)

3 (30.0)

40 (34.8)

 
  1. EBL, Estimated blood loss; MIS, Minimal invasive surgery
  2. aData are presented as number (percentage) unless indicated otherwise
  3. bData are presented as median (range)